Abstract:Epilepsy Currents, Ahead of Print. Genetic Testing in Children Enrolled in Epilepsy Surgery Program. A Real-Life Study Straka B, Splitkova B, Vlckova M, Tesner P, Rezacova H, Krskova L, Koblizek M, Kyncl M, Maulisova A, Bukacova K, Uhrova-Meszarosova A, Musilova A, Kudr M, Ebel M, Belohlavkova A, Jahodova A, Liby P, Tichy M, Jezdik P, Zamecnik J, Aronica E, Krsek P. Eur J Paediatr Neurol. 2023;47:80-87. doi:10.1016/j.ejpn.2023.09.009. PMID: 37812946 Objective:Although genetic causes of drug-resistant focal epilepsy and selected focal malformations of cortical development (MCD) have been described, a limited number of studies comprehensively analysed genetic diagnoses in patients undergoing pre-surgical evaluation, their outcomes and the effect of genetic diagnosis on surgical strategy.Methods:We analysed a prospective cohort of children enrolled in epilepsy surgery program over January 2018-July 2022. The majority of patients underwent germline and/or somatic genetic testing. We searched for predictors of surgical outcome and positive result of germline genetic testing.Results:Ninety-five patients were enrolled in epilepsy surgery program and 64 underwent resective epilepsy surgery. We ascertained germline genetic diagnosis in 13/74 patients having underwent germline gene testing (pathogenic or likely pathogenic variants in CHRNA4, NPRL3, DEPDC5, FGF12, GRIA2, SZT2, STXBP1) and identified three copy number variants. Thirty-five patients underwent somatic gene testing; we detected 10 pathogenic or likely pathogenic variants in genes SLC35A2, PTEN, MTOR, DEPDC5, NPRL3. Germline genetic diagnosis was significantly associated with the diagnosis of focal epilepsy with unknown seizure onset.Significance:Germline and somatic gene testing can ascertain a definite genetic diagnosis in a significant subgroup of patients in epilepsy surgery programs. Diagnosis of focal genetic epilepsy may tip the scales against the decision to proceed with invasive EEG study or surgical resection; however, selected patients with genetic focal epilepsies associated with MCD may benefit from resective epilepsy surgery and therefore, a genetic diagnosis does not disqualify patients from presurgical evaluation and epilepsy surgery. Utility of Genetic Testing in the Pre-Surgical Evaluation of Children With Drug-Resistant Epilepsy Alsubhi S, Berrahmoune S, Dudley RWR, Dufresne D, Simard Tremblay E, Srour M, Myers KA. J Neurol. 2024. doi:10.1007/s00415-023-12174-3. PMID: 38261030 We evaluated the utility of genetic testing in the pre-surgical evaluation of pediatric patients with drug-resistant focal epilepsy. This single-center retrospective study reviewed the charts of all pediatric patients referred for epilepsy surgery evaluation over a 5-year period. We extracted and analyzed results of genetic testing as well as clinical, EEG, and neuroimaging data. Of 125 patients referred for epilepsy surgical evaluation, 86 (69%) had some form of genetic testing. Of these, 18 (21%) had a pathogenic or likely pathogenic variant identified. Genes affected included NPRL3 (3 patients, all related), TSC2 (3 patients), KCNH1, CHRNA4, SPTAN1, DEPDC5, SCN2A, ARX, SCN1A, DLG4, and ST5. One patient had ring chromosome 20, one a 7.17p12 duplication, and one a 15q13 deletion. In six patients, suspected epileptogenic lesions were identified on brain MRI that were thought to be unrelated to the genetic finding. A specific medical therapy choice was allowed due to genetic diagnosis in three patients who did not undergo surgery. Obtaining a molecular diagnosis may dramatically alter management in pediatric patients with drug-resistant focal epilepsy. Genetic testing should be incorporated as part of standard investigations in the pre-surgical work-up of pediatric patients with drug-resistant focal epilepsy.

Epilepsy surgery outcomes in patients with GATOR1 gene complex variants: Report of new cases and review of literature

Seizure Features and Outcomes in 50 Children with GATOR1 Variants: A Retrospective Study, More Favorable for Epilepsy Surgery.

Surgical Treatment Of Children With Drug-Resistant Epilepsy Involving The Rolandic Area

Surgical Treatment in Children with Intractable Epilepsy after Viral Encephalitis

Surgical Treatment for Drug-Resistant Epilepsy Due to Early Brain Injury in Children

Clinical and genetic features of GATOR1 complex-associated epilepsy

Pediatric epilepsy surgery in patients with Lennox-Gastaut syndrome after viral encephalitis.

The landscape of epilepsy-related GATOR1 variants

The Clinical Features and Influencing Factors of Surgical Efficacy in Glioneuronal Tumors Associated-Epilepsy

Epilepsy surgery for patients with genetic refractory epilepsy: a systematic review

C.1 Utility of genetic testing in the pre-surgical evaluation of children with drug-resistant epilepsy

Epilepsy outcome and pathology analysis for ganglioglioma: A series of 51 pediatric patients

Pathways to epilepsy surgery in children with tuberous sclerosis complex-associated epilepsy

Genetic Testing in the Presurgical Evaluation of Drug-Resistant Epilepsy: Bells and Whistles or Nuts and Bolts?

Trends, outcomes, and complications of surgery for lesional epilepsy in infants and toddlers: A multicenter study

Utility of genetic testing in the pre-surgical evaluation of children with drug-resistant epilepsy

Epilepsy surgery in children with operculoinsular epilepsy: Results of a large unicentric cohort

Clinical Phenotypes of Epilepsy Associated with GABRA1 Gene Variants

231 Postoperative Seizure Outcome of a Cohort of Patients With Drug Resistant Epilepsy and Malformations of Cortical Development Selected Predominantly by Non-invasive Evaluation

Epilepsy surgery in children with operculo-insular epilepsy: Results of a large unicentric cohort

Seizure outcome in surgically treated pediatric gangliogliomas and dysembryoplastic neuroepitheliomas according to imaging and resection strategies